Latest Updates on Yaz Settlements from Bayer

Share Article

The Yaz Resource Center is the Web’s largest source for information on Yaz research, side effects and legal news. Visit http://www.YazLawsuit.com

YAZ LAWSUIT
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may be due to taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

German drug maker Bayer has indicated to shareholders in its latest financial report that it will reserve an additional $262.5 million to settle Yaz and Yasmin lawsuits over blood clots, according to Dow Jones staff writer Friedrich Geiger on October 30, 2012 in an article for 4-traders.com.

The news follows a previous Bloomberg report on July 31st that Bayer would set aside $610 million to settle more Yaz cases at that time, for an average of nearly $212,000 per case. The report also stated Yaz settlements would be limited to cases involving blood clot injuries.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may be attributed to Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

Last month, the American College of Obstetricians and Gynecologists issued a new warning on the safety of birth control pills containing drospirenone like Yaz and Yasmin. According to the Chicago Tribune on October 24th, the group warned these drugs may have a higher risk of causing blood clots.

On October 25, 2011, the British Medical Journal published a study from the University of Copenhagen linking the hormone in Yaz to blood clots. On October 27, 2011, the FDA released its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" showing drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

A federal Multi-District Litigation court was established in Illinois to handle Yaz lawsuits filed by those injured. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). The court estimates that more than 10,000 patients have filed a claim.

The news of additional Yaz lawsuit settlements is positive for those injured who have yet to file a claim. However, time is limited and only certain cases may qualify.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may be due to taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website